Rep. Nancy Mace (R-SC) officially laid out her cannabis legalization plan on Monday. Titled the States Reform Act and co-sponsored by at least a half-dozen Republicans, the plan would essentially legalize cannabis on a federal level “in a manner consistent with the right of states to determine what level of cannabis reform or legalization each state wants to regulate, or not.”
Highlights of the bill:
- Federally decriminalizes cannabis and fully defers to state powers over prohibition and commercial regulation
- Regulates cannabis products like alcohol products
- Institutes a 3% federal excise tax on those products to fund law enforcement and small business programs.
- Ensures the continued existence of state medical cannabis programs and patient access while allowing for new medical research and products to be developed
- Protects our veterans by ensuring they will not be discriminated against in federal hiring for cannabis use or lose their VA healthcare for following their doctor’s advice to use medical cannabis
- Protects children and young adults under 21 from cannabis products and advertising nationwide
- Protects medical cannabis for the following uses: arthritis, cancer, chronic pain, sickle cell, HIV/AIDS, PTSD and other medical uses per a state’s specific cannabis regulations.
Taxes: An Issue in the Democratic Cannabis Legalization Bill
By comparison, the proposed legislation to legalize cannabis from democratic senators Chuck Schumer, Cory Booker and Ron Wyden would carry an excise tax of 25.5%, viewed as unreasonably high, especially for small businesses.
Weldon Angelos is the co-coordinator of the Cannabis Freedom Alliance (CFA). He worked with Mace’s team in crafting this legislation. In conversation with Benzinga, he said “The States Reform Act represents exciting movement towards compromise on the cannabis criminal justice issue and progress-building on the First Step Act. Representative Mace is bringing constructive solutions that promise to bring more Republicans to the table to end an unjust root cause of mass incarceration.”
When news of the GOP-led legalization draft was initially reported, it seemed clear that a republican effort would be essential for any real legal movement to proceed.
“If legalization efforts are approved in both houses, we don’t need President Biden’s signature,” said Angelos, pointing to the obvious prohibitionist tendencies of the President. “This could be it.”
Cannabis stocks, which were trading up earlier in the day, tumbled following the news.
Equities to watch include:
- Curaleaf Holdings Inc CURLF
- Green Thumb Industries Inc GTBIF
- Trulieve Cannabis Corp (OTC: TCNNF)
- AdvisorShares Pure US Cannabis ETF MSOS
- ETFMG US Alternative Harvest ETF MJUS
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Meet the biggest cannabis industry players and make deals that will push the industry forward.
Featuring live company presentations, insider panels, and unmatched access to networking, the Benzinga Cannabis Capital Conference is where cannabis executives and entrepreneurs meet.
Join us April 11-12, 2023 at Fontainebleau Miami Beach in sunny Florida.